Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test could Fine-Tune breast cancer therapy

NCT ID NCT06666439

Recruiting now Knowledge-focused Sponsor: Julia Foldi Source: ClinicalTrials.gov ↗

First seen Jan 23, 2026 · Last updated May 05, 2026 · Updated 15 times

Summary

This study explores whether a blood test that measures tumor DNA (ctDNA) can help doctors adjust treatment early for people with metastatic lobular breast cancer. About 20 participants will have their ctDNA levels tracked while on standard hormone therapy. The goal is to see if changes in ctDNA can signal whether the treatment is working or needs to be changed, potentially avoiding unnecessary side effects or delays.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC INVASIVE LOBULAR CARCINOMA (MILC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Magee Women's Hospital of UPMC

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

METASTATIC INVASIVE LOBULAR CARCINOMA (MILC)